← Back to Search

Other

Ibuprofen and acetaminophen for Postoperative Pain (MOPAC Trial)

Phase 3
Waitlist Available
Research Sponsored by Milton S. Hershey Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 3 morning (4 am - 10 am)
Awards & highlights

MOPAC Trial Summary

This trial is testing if a combination of acetaminophen and ibuprofen is more effective than ibuprofen alone in relieving post-operative pain for patients who have had a Cesarean delivery.

Eligible Conditions
  • Postoperative Pain
  • Opioid Use Disorder

MOPAC Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 2 morning (4 am - 10 am)
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 2 morning (4 am - 10 am) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Pain
Secondary outcome measures
Opiate consumption in hospital
Opiate consumption week 1
Opiate consumption week 2
+9 more

MOPAC Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Ibuprofen and acetaminophenActive Control2 Interventions
Oral administration of ibuprofen 600 mg tablet and acetaminophen 650 mg tablet every 6 hours
Group II: Ibuprofen and placeboPlacebo Group2 Interventions
Oral administration of ibuprofen 600 mg tablet and placebo tablet every 6 hours

Find a Location

Who is running the clinical trial?

Milton S. Hershey Medical CenterLead Sponsor
492 Previous Clinical Trials
2,798,773 Total Patients Enrolled
2 Trials studying Postoperative Pain
196 Patients Enrolled for Postoperative Pain

Media Library

Acetaminophen (Other) Clinical Trial Eligibility Overview. Trial Name: NCT03929640 — Phase 3
Postoperative Pain Research Study Groups: Ibuprofen and placebo, Ibuprofen and acetaminophen
Postoperative Pain Clinical Trial 2023: Acetaminophen Highlights & Side Effects. Trial Name: NCT03929640 — Phase 3
Acetaminophen (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03929640 — Phase 3

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the most up-to-date information on Ibuprofen and acetaminophen's FDA approval status?

"Both Ibuprofen and acetaminophen have extensive Phase 3 trial data supporting their efficacy and safety, so they each received a score of 3."

Answered by AI

How many test subjects are a part of this experiment?

"The clinicaltrials.gov website contains information indicating that this study is currently looking for patients to enroll. This trial was originally posted on 8/5/2019, and the most recent update was on 9/26/2022. A total of 144 patients are needed from 1 location."

Answered by AI

For what primary reasons are people taking Ibuprofen and acetaminophen?

"Inflammation of the mucous membranes, excessive discharge of mucus from the nose, and pain in the muscles and bones can all be treated using Ibuprofen and acetaminophen."

Answered by AI

Are new participants currently being sought for this experiment?

"From what is available on clinicaltrials.gov, this study is still recruiting patients and seeking new participants. The trial was originally posted on 8/5/2019, with the most recent update being 9/26/2022."

Answered by AI

Could you please list other research projects that have studied Ibuprofen and acetaminophen?

"Currently, there are 118 ongoing trials studying the effects of ibuprofen and acetaminophen. Of these active studies, 36 are in Phase 3. Most of the research regarding Ibuprofen and acetaminophen is centred in Pittsburgh, Pennsylvania; however, there are 1037 locations running these types of trials."

Answered by AI
Recent research and studies
~9 spots leftby Apr 2025